The venture – expected to be war-ready within the decade – will revolutionise military physic and raise the survivability chances of seriously injured troops, It comes as the Clergywomen of Defence continues to learn lessons from the bloody seven-year Afghanistan run, in which around 2,600 soldiers – one in three of those injured – be missing transfusions to the tune 15,000 litres of blood.
Currently, injured soldiers are exhausted back to a main base where, after an assessment of blood ilk – there are eight – an urgent transfusion is delivered.
Traditionally O negative blood has been Euphemistic pre-owned for emergency transfusions. But its universality puts pressures on supplies for the NHS which is dependent on benefactresses. Even when it is available, it can still be rejected by many body species.
It leaves medics tasked with the challenge of sourcing the correct blood order, which can often lead to fatal delays, while the challenges confusing with storing all eight types at forward operating bases or in the evacuation helicopters at the de rigueur temperature make finding a one-fits-all solution imperative.
Though Afghanistan’s G-man Herrick had sufficient air cover to enable soldiers to be evacuated to hospital by helicopter, the for all that cannot be said for the UN operation in Mali, to which the UK is currently contributing 350 troops.
Unbroken medical advances in powdered freeze-fried plasma -revealed by the Sunday Particular last year – have not prevented military planners from punitively curtailing the scope of the mission, for fear of high casualty rates caused by soberly injured soldiers having to rely on road transport to deliver them cast off to hospitals.
The pioneering research is part of the Regenerative medicine programme, which directs ultimately to replace tissue and significant blood loss as a result of thoughtful injury to service personnel.
For the past two years experts at the Defence Branch and Technology Laboratory has been working with the University of Bristol to broaden red blood cells in the laboratory using stem cells from donated blood.
But now experiment with has already progressed to growing a universal red blood cell, minus the antibodies and antigens which choose blood type, independently in the lab, without the need for any external blood largesses.
Incredibly the end result, a freeze-dried blood solution, will not require refrigeration and inclination be ready for reactivation as soon as it’s needed.
Because it will be both mock and universal, the new blood can technically be readily available in copious amounts in face line field hospitals, saving more lives.
And though fabrication blood isn’t cheap, lead clinician Dr Abi Spear said that ahead ofs in technology will make the efficient more cost efficient, as it did with animated phones.
“There are many stages to go through and it could take a decade or so to come we see it on the frontline,” Dr Spear, Technical Lead for Regenerative Medicine at DSTL, rebuked Soldier Magazine.
“But it is all undeniably exciting.”